Differential Expression of Type III Effector BteA Protein Due to IS481 Insertion in Bordetella pertussis

The epidemiology of pertussis in Germany: past and present

(2009) Wiebke Hellenbrand et al.   BMC INFECTIOUS DISEASES

TheBordetellatype III secretion system effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts

(2009) Christopher T. French et al.   CELLULAR MICROBIOLOGY

Virulence factor secretion and translocation by Bordetella species

(2009) Ruchi Shrivastava et al.   CURRENT OPINION IN MICROBIOLOGY

Changes in Genetic Diversity of the Bordetella pertussis Population in the United Kingdom between 1920 and 2006 Reflect Vaccination Coverage and Emergence of a Single Dominant Clonal Type

(2009) D. J. Litt et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Bordetellaevades the host immune system by inducing IL-10 through a type III effector, BopN

(2009) Kanna Nagamatsu et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: Identification of genes absent from epidemic strains

(2008) Audrey J King et al.   BMC GENOMICS

Bordetella pertussis Expresses a Functional Type III Secretion System That Subverts Protective Innate and Adaptive Immune Responses

(2008) N. K. Fennelly et al.   INFECTION AND IMMUNITY

Is the Sequenced Bordetella pertussis Strain Tohama I Representative of the Species?

(2008) V. Caro et al.   JOURNAL OF CLINICAL MICROBIOLOGY

BordetellaBsp22 forms a filamentous type III secretion system tip complex and is immunoprotectivein vitroandin vivo

(2008) Bob Medhekar et al.   MOLECULAR MICROBIOLOGY

Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan

(2008) Hyun-Ja Han et al.   VACCINE